Procept Biorobotics Corporation

06/10/2026 | Press release | Distributed by Public on 06/10/2026 14:34

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
The annual meeting of stockholders (the "Annual Meeting") of PROCEPT BioRobotics Corporation (the "Company") was held on June 9, 2026.
All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2029 annual meeting of stockholders, or until his or her successor is duly elected or appointed, by the following vote:
Name of Nominee Votes For Votes Withheld Broker Non-Votes
Antal Desai
28,444,121
8,511,185
10,418,057
Mary Garrett
29,150,610
7,804,696
10,418,057
Frederic Moll, M.D.
36,455,610
499,696
10,418,057
Proposal 2 in the Proxy Statement, a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:
Votes For Votes Withheld Abstentions
47,328,539 21,691 23,133
Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote:
Votes For Votes Withheld Abstentions Broker Non-Votes
26,984,867 9,924,704 45,735 10,418,057
Procept Biorobotics Corporation published this content on June 10, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 10, 2026 at 20:34 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]